Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trialWinette T.A. van der Graaf, Peter Hohenberger, Arthur P. Staddon et al.|The Lancet|2012Cited by 2.1k
An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32)Anne Brédart, Neil K. Aaronson, Andrew Bottomley et al.|European Journal of Cancer|2005Cited by 241
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancerJane Blazeby, Corneel Coens, Thierry Conroy et al.|European Journal of Cancer|2004Cited by 225
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trialAndrew Bottomley, Daniil Stroyakovskiy, Corneel Coens et al.|The Lancet Oncology|2021Cited by 72